z-logo
open-access-imgOpen Access
Third-generation tyrosine kinase inhibitor in the treatment of epidermal growth factor receptor mutated squamous cell lung cancer: a tailored therapy approach
Author(s) -
Francesco Cortiula,
Giovanna De Maglio,
Maria Giulia Cangi,
Lorenzo Gerratana,
C. Lisanti,
Salvatore Bonura,
Gianpiero Fasola,
Alessandro Follador
Publication year - 2019
Publication title -
annals of translational medicine
Language(s) - English
Resource type - Journals
eISSN - 2305-5847
pISSN - 2305-5839
DOI - 10.21037/atm.2018.12.42
Subject(s) - cancer research , epidermal growth factor receptor , tyrosine kinase , lung cancer , squamous cell cancer , tyrosine kinase inhibitor , medicine , epidermal growth factor , receptor tyrosine kinase , receptor , cancer , oncology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom